Proteases and protease inhibitors in chronic obstructive lung disease.
D001991:Bronchitis / Q000201:enzymology; D002908:Chronic Disease; D006801:Humans; D008168:Lung / Q000201:enzymology*; D008173:Lung Diseases, Obstructive / Q000201:enzymology* / Q000628:therapy; D008264:Macrophages / Q000201:enzymology; D010447:Peptide Hydrolases / Q000378:metabolism*; D011480:Protease Inhibitors; D011650:Pulmonary Alveoli / Q000201:enzymology; D011656:Pulmonary Emphysema / Q000201:enzymology / Q000209:etiology; D012907:Smoking / Q000150:complications; D013379:Substrate Specificity; D000515:alpha 1-Antitrypsin / Q000502:physiology; D019896:alpha 1-Antitrypsin Deficiency; D000511:alpha-Macroglobulins / Q000502:physiology
D011480:Protease Inhibitors; D000515:alpha 1-Antitrypsin; D000511:alpha-Macroglobulins; D010447:Peptide Hydrolases